Immunizing school-age children and adolescents: Experience from low- and middle-income countries

Vaccine

Volumn 28, Issue 5, 2010, Pages 1138-1147

  Mackroth, Maria Sophia ^a   Irwin, Kathleen ^b   Vandelaer, Jos ^c   Hombach, Joachim ^b   Eckert, Linda O ^b,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNICEF   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Immunization; Low income; Middle income; School age children; Vaccine

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; TYPHOID VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

AGE DISTRIBUTION; CHICKENPOX; CHILD HEALTH CARE; CONGENITAL RUBELLA SYNDROME; DEVELOPING COUNTRY; DIPHTHERIA; DISEASE CONTROL; EPIDEMIC ENCEPHALITIS; EPIDEMIC MENINGITIS; GROUPS BY AGE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; MASS IMMUNIZATION; MEASLES; MEASLES VACCINATION; MUMPS; PERTUSSIS; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; RUBELLA; SCHOOL; TETANUS; TETANUS PROPHYLAXIS; TYPHOID FEVER; VIRUS INFECTION; YELLOW FEVER;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; IMMUNIZATION; MALE; NATIONAL HEALTH PROGRAMS; SOCIOECONOMIC FACTORS;

EID: 74149091356     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.008     Document Type: Review

References (82)

1. WHO/UNICEF, GIVS-Global Immunization and Vaccination Strategy, 2006-15; 2005.
2. World Health Organization. Immunization schedules by disease covered by antigens within age range (2008)
3. Brabin L., Greenberg D.P., Hessel L., Hyer R., Ivanoff B., and Van Damme P. Current issues in adolescent immunization. Vaccine 26 August(33) (2008) 4120-4134 [Epub 2008 May 12, Review]
4. Langiano E., Lanni L., Ferrara M., Atrei P., Martellucci G., and De Vito E. Preventable infectious diseases using vaccination in developmental age in the province of Frosinone, Italy. J Prev Med Hyg 48 3 (2007) 97-102
5. Ortega-Sanchez I.R., Meltzer M.I., Shepard C., Zell E., Messonnier M.L., Bilukha O., et al. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis 46 1 (2008) 1-13
6. Shah N.K. Adolescent vaccination. J Indian Med Assoc 103 11 (2005) 626-628
7. The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent-grade cervical lesions. N Engl J Med 356 19 (2007) 1915-1927
8. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmerón J., Wheeler C.M., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 (2007) 2161-2170
9. WHO Global strategies, policies and practices for immunization of adolescents. A review (1999)
10. Wilson T.R. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis. J Pediatr Health Care 20 4 (2006) 229-237
11. Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. Wkly Epidemiol Rec 77 40 (2002) 331-339
12. Pertussis vaccines-WHO position paper. Wkly Epidemiol Rec 80 4 (2005) 31-39
13. Tetanus vaccine. Wkly Epidemiol Rec 81 20 (2006) 198-208
14. Diphtheria vaccine. Wkly Epidemiol Rec 81 3 (2006) 24-32
15. Japanese encephalitis vaccines. Wkly Epidemiol Rec 81 34/35 (2006) 331-340
16. Typhoid vaccines: WHO position paper. Wkly Epidemiol Rec 83 6 (2008) 49-59
17. World Health Organization. Global immunization data (2007)
18. Steinglass R. Using early childhood booster doses to maintain the elimination of neonatal tetanus (1998), Published for the U.S. Agency for International Development (USAID) by the Basic Support for Institutionalizing Child Survival (BASICS) Project, Arlington, VA
19. Farizo K.M., Cochi S.L., Zell E.R., Brink E.W., Wassilak S.G., and Patriarca P.A. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 14 3 (1992) 708-719
20. FitzSimons D., Vorsters A., Hoppenbrouwers K., Van Damme P., Viral Hepatitis Prevention Board (VHPB), and European Union for School and University Health and Medicine (EUSUHM). Prevention and control of viral hepatitis through adolescent health programmes in Europe. Vaccine 25 52 (2007) 8651-8659
21. Rubella vaccines. Wkly Epidemiol Rec 75 20 (2000) 161-172
22. Measles initiative, www.measlesinitiative.org [accessed 5.05.08].
23. New goal for vaccination programs in the region of the Americas: to eliminate rubella and congenital rubella syndrome. Rev Panam Salud Publica 14 5 (2003) 359-363
24. PAHO. Vaccination weeks in the Americas. Final report. Available at http://www.paho.org/English/DD/PIN/VWA_07_Final_Report.pdf; 2007.
25. Singizi T. Zimbabwe's child health days help to reduce measles and boost survival. Available at: http://www.unicef.org/infobycountry/zimbabwe_41970.html; 2007.
26. Castillo-Solórzano C., and Andrus J.K. Rubella elimination and improving health care for women. Emerg Infect Dis 10 November (11) (2004) 2017-2021
27. Castillo-Solórzano C., Carrasco P., Tambini G., Reef S., Brana M., and de Quadros C.A. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 187 May(Suppl. 1) (2003) S146-S152
28. Castillo-Solórzano C., Marsigli C., Bravo Alcántara P., Andrus J.K., Filippis A.M.B., Danovaro-Holliday M.C., et al. Progress toward elimination of rubella and congenital rubella syndrome-the Americas, 2003-2008. JAMA 301 3 (2009) 266-268
29. Cholera vaccine. Wkly Epidemiol Rec 76 (2001) 117-124
30. Hepatitis A vaccines. Wkly Epidemiol Rec February (2000) 37-44 [75th year]
31. Hepatitis B vaccines. Wkly Epidemiol Rec 79 28 (2004) 255-263
32. Human papillomavirus. Wkly Epidemiol Rec 84 15 (2009) 118-132
33. Measles vaccines. Wkly Epidemiol Rec 79 14 (2004) 130-142
34. Mumps virus vaccines. Wkly Epidemiol Rec 82 7 (2007) 51-60
35. Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 73 32 (1998) 241-248
36. Yellow fever vaccine. WHO position paper. Wkly Epidemiol Rec 78 40 (2003) 349-359
37. People's Daily Online. Nepal to expand school immunization to more districts; 2006 [accessed 06.08].
38. Koulova A., Tsui J., Irwin K., Van Damme P., Biellik R., and Aguado M.T. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine 26 December (51) (2008) 6529-6541
39. Eckert LO, LaMontagne DS, Jumaan A, Hombach J. Current status of HPV vaccine implementation in middle and low income countries. In: 25th International Papillomavirus Conference, 8-14 May 2009, 29-19, http://www.hpv2009.org.
40. Nakhla I., Frenck Jr. R.W., Teleb N.A., El Oun S., Sultan Y., Mansour H., et al. The Changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. Vaccine 23 25 (2005) 3288-3293
41. WHO and UN Foundation: immunization in practice 2004 update, p. 28 (Section 5).
42. http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragett2plus.htm
43. http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index5.html (accessed 21.05.09).
44. Validation of neonatal tetanus elimination in Nepal by lot quality assurance-cluster sampling. Wkly Epidemiol Rec 81 (2006) 120-127
45. 24 horas libre. Nobel que descubrió virus de hepatitis B sorprendido con campaña de vacunación en Perú (2008). http://www.24horaslibre.com/salud/1207263309.php http://www.24horaslibre.com/salud/1207263309.php [accessed .05.08]
46. Progress in global measles control and mortality reduction, 2000-2007. Wkly Epidemiol Rec 83 (2008) 441-448
47. PAHO. Eliminacion de la rubeola y el sindrome de rubeola congenita. Available on www.paho.org; 2005.
48. Immunization Basics, USAID. WHO: periodic intensification of routine immunization. Pre-print release. Available at: http://www.immunizationbasics.jsi.com/Docs/PIRImonograph_Feb09.pdf; 2009 [accessed 22.05.09].
49. Child days plus in Uganda: best practices and challenges. In: Presentation at the 2009 Global Immunization Meeting, downloadable from: http://www.technet21.org/Tools_and_resources/GIM_documents.htm [accessed 22.05.09].
50. Biellik R., Levin C., Mugisha E., Lamontagne D.S., Bingham A., Kaipilyawar S., et al. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine (2009) [Epub ahead of print]
51. Flisser A., Valdespino J.L., García-García L., Guzman C., Aguirre M.T., Manon M.L., et al. Using national health weeks to deliver deworming to children: lessons from Mexico. J Epidemiol Community Health 62 4 (2008) 314-317
52. Personal communication-Dr Giorgi Kurtsikashvili, WHO, Georgia.
53. Szilagyi P.G., Rand C.M., McLaurin J., Tan L., Britto M., Francis A., et al. Working group on adolescent vaccination in the medical home delivering adolescent vaccinations in the medical home: a new era?. Pediatrics 121 January(Suppl. 1) (2008) S15-S24 [Review]
54. Middleman A.B. Adolescent immunizations: policies to provide a shot in the arm for adolescents. J Adolesc Health 41 August(2) (2007) 109-118 Review
55. Middleman A.B. New adolescent vaccination recommendations and how to make them "stick". Curr Opin Pediatr 19 August(4) (2007) 411-416
56. World Health Organization. The status of School Health. Geneva, http://whqlibdoc.who.int/hq/1996/WHO_HPR_HEP_96.1.pdf; 1996.
57. Morita J.Y., Ramirez E., and Trick W.E. Effect of a school-entry vaccination requirement on racial and ethnic disparities in hepatitis B immunization coverage levels among public school students. Pediatrics 121 3 (2008) pe547-pe552
58. Lixia W., Guang Z., Lee L.A., Zhiwei Y., Jingjin Y., Jun Z., et al. Progress in accelerated measles control in the People's Republic of China, 1991-2000. J Infect Dis 187 May(Suppl. 1) (2003) S252-S257
59. Nwaorgu O.C., Okeibunor J., Madu E., Amazigo U., Onyegegbu N., and Evans D. A school-based schistosomiasis and intestinal helminthiasis control programme in Nigeria: acceptability to community members. Trop Med Int Health 3 10 (1998) 842-849
60. Woodruff B.A., Unti L., Coyle K., and Boyer-Chuanroong L. Parents' attitudes toward school-based hepatitis B vaccination of their children. Pediatrics 98 3(Pt 1) (1996) 410-413
61. Hinds A., and Cameron J.C. Acceptability of universal hepatitis B vaccination among school pupils and parents. Commun Dis Public Health 7 4 (2004) 278-282
62. UNICEF: State of the World's Children 2009, p. 137.
63. World Health Organization. School immunization in Indonesia. http://www.who.int/immunization_delivery/systems_policy/Indonesia-School-immunization.pdf; 2007.
64. World Health Organization. School immunization programme in Malaysia. http://www.who.int/immunization_delivery/systems_policy/Malaysia-school-immunization.pdf; 2008.
65. World Health Organization. School immunization programme in Sri Lanka, http://www.who.int/immunization_delivery/systems_policy/SriLanka-school-immunization.pdf; 2008.
66. Bosu W.K., Essel-Ahun M., Adjei S., and Strebel P. Progress in the control of measles in Ghana, 1980-2000. J Infect Dis 187 May(Suppl. 1) (2003) S44-50
67. Magnussen P., Ndawi B., Sheshe A.K., Byskov J., and Mbwana K. Malaria diagnosis and treatment administered by teachers in primary schools in Tanzania. Trop Med Int Health 6 4 (2001) 273-279
68. Stevens W., and Walker D. Adolescent vaccination in the developing world: time for serious consideration?. Vaccine 22 5-6 (2004) 781-785
69. Kane M.A., Sherris J., Coursaget P., Aguado T., and Cutts F. Chapter 15: HPV vaccine use in the developing world. Vaccine 24 Suppl. 3 (2006) S3/132-139
70. IRIN. Pakistan: final push in measles campaign. http://www.irinnews.org/report.aspx?ReportID=75300; 2007 [accessed 10.07.08].
71. The Measles Initiative. Virtual journeys: Ghana. http://www.measlesinitiative.org/ghana_trip/day1.asp; 2005 [accessed 10.07.08].
72. Munyoro M.N., Kufa E., Biellik R., Pazvakavambwa I.E., and Cairns K.L. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001. J Infect Dis 187 May(Suppl. 1) (2003) S91-S96
73. Vijayaraghavan M., Lievano F., Cairns L., Wolfson L., Nandy R., Ansari A., et al. Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003. Disasters 30 June(2) (2006) 256-269
74. Vandelaer J., Bilous J., and Nshimirimana D. Reaching Every District (RED) approach: a way to improve immunization performance. Bull World Health Organ 86 3 (2008)
75. US Fund for UNICEF: Nepal and Yemen- Crossing Mountains to help mothers and babies. MNT Monitor Fall 2004; No. 8.
76. http://origin-www.unicef.org/health/ethiopia_37790.html
77. WHO/EURO. European immunization week. Available under http://www.euro.who.int/eiw [accessed .08.08].
78. Morice A., Carvajal X., León M., Machado V., Badilla X., Reef S., et al. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. J Infect Dis 187 May(Suppl. 1) (2003) S158-S163 [Review]
79. Bryce J.W., Cutts F.T., and Saba S. Mass immunisation campaigns and quality of immunisation services. Lancet 335 8691 (1990) 739-740
80. http://www.gavialliance.org/about/in_finance/index.php [accessed 22.05.09].
81. http://www.theglobalfund.org/documents/publications/progressreports [accessed 22.05.09].
82. Wolfson L.J., Gasse F., Lee-Martin S.-P., Lydon P., Magan A., Tibouti A., et al. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ 86 January(1) (2008) 27-39